 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- ||||||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
Trial termination: Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (clinicaltrials.gov) - Jul 6, 2022
P3, N=59, Terminated, Sponsor: Ocugen
Completed --> Terminated; Primary endpoint was not met.
- ||||||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
Trial completion: Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) (clinicaltrials.gov) - Jul 1, 2020
P3, N=241, Completed, Sponsor: Ocugen
Completed --> Terminated; Primary endpoint was not met. Recruiting --> Completed
- ||||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
Trial completion: Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (clinicaltrials.gov) - Jul 1, 2020
P3, N=61, Completed, Sponsor: Ocugen
Recruiting --> Completed Recruiting --> Completed
- | brimonidine tartarate nanoemulsion (OCU300) / Ocugen
Trial completion date, Trial primary completion date: Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (clinicaltrials.gov) - Aug 4, 2019
P3, N=60, Recruiting, Sponsor: Ocugen
Recruiting --> Completed Trial completion date: Jan 2020 --> Aug 2020 | Trial primary completion date: Jul 2019 --> Jul 2020
- |||||||||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
New P3 trial: Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) (clinicaltrials.gov) - Dec 24, 2018
P3, N=240, Recruiting, Sponsor: Ocugen
- |||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
Enrollment open: Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (clinicaltrials.gov) - Sep 25, 2018
P3, N=60, Recruiting, Sponsor: Ocugen
Trial completion date: Jan 2020 --> Aug 2020 | Trial primary completion date: Jul 2019 --> Jul 2020 Not yet recruiting --> Recruiting
- |||||||| brimonidine tartarate nanoemulsion (OCU300) / Ocugen
New P3 trial: Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease (clinicaltrials.gov) - Jul 19, 2018
P3, N=60, Not yet recruiting, Sponsor: Ocugen